Titlebook: Vaccines, Medicines and COVID-19; How Can WHO Be Given Germán Velásquez Book‘‘‘‘‘‘‘‘ 2022 SC: South Centre 2022 COVID-19 Coronavirus pandem

Largess

2192-3698 lic health governance for health R&D.Discusses the lessons oThis open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exer

SCORE

COVID-19 Vaccines: Between Ethics, Health and Economics,Never in the history of medicine has a vaccine been developed in such a short time. The good news of science’s rapid response has left us with questions about immunity and contagion. New problems have arisen such as the so-called ‘vaccine nationalism’. Equity-preserving responses, such as the COVAX

新手

,Medicines and Intellectual Property: 10 Years of the WHO Global Strategy,ember States of the World Health Organization (WHO), were the result of a deadlock in the 2006 World Health Assembly where the Member States were unable to reach an agreement on what to do with the 60 recommendations in the report on Public Health, Innovation and Intellectual Property submitted to t

Aspirin

Rethinking Global and Local Manufacturing of Medical Products After COVID-19,ssion about the role of local pharmaceutical production in addressing the health needs in developing countries. The COVID-19 crisis has highlighted the interdependencies in the global production of pharmaceuticals – no country is self-sufficient. Many industrialised countries are making the decision

buoyant

Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock,urgency the discussion about the research and development (R&D) model for pharmaceuticals and other health technologies. The COVID-19 crisis shows that there is an urgent need to re-design the global public health governance for health R&D. The adoption of a binding instrument – as allowed by Articl

Mawkish

极少

Acupressure

空中

The World Health Organization Reforms in the Time of COVID-19,s funding is not sustainable and adequate to respond to the challenge. This chapter seeks to identify the main problems faced by the WHO and the necessary measures that a reform of the Organization would have to take.

休战